Bosentan Makpharm 62,5 mg filmom obložene tablete
| Name | Bosentan Makpharm 62,5 mg filmom obložene tablete |
|---|---|
| Marketing Authorisation Number | HR-H-210843347 |
| Active Substance | bosentan hidrat |
| Composition | jedna filmom obložena tableta sadrži 62,5 mg bosentana (u obliku bosentan hidrata) |
| Pharmaceutical Form | filmom obložena tableta |
| Manufacturer | Pharmascience International Limited, Nicosia, Cipar GE Pharmaceuticals Ltd., Botevgrad, Bugarska |
| Marketing Authorisation Holder | Makpharm d.o.o., Trnjanska cesta 37/1, Zagreb, Hrvatska |
| Marketing Authorisation Date | 24.01.2020 |
| MA Period of Validity | unlimited |
| Classification Number | UP/I-530-09/19-02/229 |
| Registration Number | 381-12-01/30-20-03 |
| Prescription | Medicinal product subject to medical prescription |
| Type of prescription | ograničeni recept |
| Distribution | Supply through pharmacies (community) |
| Advertising to general public | not allowed |
| ATC Code | C02KX01 |
| Marketing status | stavljeno u promet |
| Shortage status | nema nestašice |
| SmPC | download |
| PL | download |
| Public Assessment Report | download |
| Educational materials for patients / caregivers |
Knjižica za bolesnika s važnim uputama za sigurnu primjenu lijeka, verzija 2 |
